Sector ratings Incyte Corporation

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 16/07/2026 BST			5-day change	1st Jan Change
116.65 ^USD	+1.36%		-1.58%	+18.10%

07-15	BofA Securities Raises Incyte Price Target to $136 From $124	MT
07-14	Barclays Adjusts Incyte Price Target to $134 From $117, Maintains Overweight Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Visibility
INCYTE CORPORATION	23.3B	-	AA	-	-
REGENERON PHARMACEUTICALS, INC.	69.07B		BBB
UCB	51.77B		AA
SAMSUNG BIOLOGICS CO.,LTD.	43.63B		BBB
CSL LIMITED	40.89B		A
BIOGEN INC.	30.84B		AA
MODERNA, INC.	25.06B	-	BBB	-	-
INNOVENT BIOLOGICS, INC.	20.92B		AAA
SWEDISH ORPHAN BIOVITRUM AB	16.71B		AA
BRIDGEBIO PHARMA, INC.	15.74B	-	BB	-	-
AXSOME THERAPEUTICS, INC.	12.2B	-	BBB	-	-
BIOMARIN PHARMACEUTICAL INC.	11.6B		BBB		-
ALTEOGEN INC.	10B		CCC
KRYSTAL BIOTECH, INC.	10.08B	-	B	-	-
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	6.76B	-	-	-	-	-
GRIFOLS, S.A.	6.29B		BB
GAN & LEE PHARMACEUTICALS.	6.1B		-		-
3SBIO INC.	5.71B		A
TWIST BIOSCIENCE CORPORATION	5.68B	-	BB	-	-
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	5.58B	-	BB	-	-	-
Average	20.9B		A
Weighted average by Cap.			A